FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2049500768> ?p ?o ?g. }

• W2049500768 endingPage "2793" @default.
• W2049500768 startingPage "2790" @default.
• W2049500768 abstract "HomeCirculationVol. 92, No. 10There May Be More to Myocardial Viability Than Meets the Eye! Free AccessResearch ArticleDownload EPUBAboutView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessResearch ArticleDownload EPUBThere May Be More to Myocardial Viability Than Meets the Eye! Sanjiv Kaul Sanjiv KaulSanjiv Kaul From the Cardiovascular Division, University of Virginia School of Medicine, Charlottesville. Search for more papers by this author Originally published15 Nov 1995https://doi.org/10.1161/01.CIR.92.10.2790Circulation. 1995;92:2790–2793According to the Oxford English Dictionary, “viable” means “capable of living.”1 Incorrectly, the terms viable and capable of contracting in the presence of adequate blood flow have been used interchangeably for the myocardium. Consequently, it has been suggested that viable myocardium is only that which demonstrates improved thickening after restoration of blood flow.2This definition of viability is inaccurate because it ignores a fundamental physiological principle: that at rest, most left ventricular wall thickening occurs as a result of endocardial thickening; the middle layer of the myocardium contributes only modestly to thickening; and the contribution of the epicardium is negligible (Fig 1).34 Thus, if the endocardium is necrosed, wall thickening will be significantly diminished at rest even if blood flow is restored to the middle and outer thirds of the ventricular wall.5 When infarction involves <20% of the wall thickness, hypokinesia is noted. When it involves ≥20% of the wall thickness, akinesia or dyskinesia is seen.6Defining viability as recovery in regional function after revascularization also presupposes that revascularization successfully restores resting nutrient blood flow to normal levels. It ignores the all too frequent occurrence of inadequate revascularization for technical reasons, poor distal runoff, or the presence of abnormal microvasculature within the revascularized bed.7Thus, defining viability as recovery of regional function after a revascularization procedure is inaccurate, albeit expedient. Ideally, the definition of viability should be as simple as that in the Oxford English Dictionary. It should also be independent of the result of an intervention, be it percutaneous or surgical. The ideal imaging method for assessing viability should be able to delineate infarcted from noninfarcted tissue with the same resolution as shown in Fig 2, in which infarction represents nonviable tissue and the rest of the heart represents viable myocardium. There may be several benefits to nonischemic viable myocardium even if it does not demonstrate systolic thickening at rest. Although the middle and outer layers of the myocardium thicken little at rest, they thicken more with catecholamine stimulation8 and may thus contribute to overall wall thickening and an increase in global left ventricular systolic performance during exercise and other forms of stress. The presence of viable myocardium in the outer layers of the ventricular wall may also contribute to maintenance of left ventricular shape and size by preventing infarct expansion (Fig 2) and subsequent heart failure and thus reduce late mortality after acute myocardial infarction.591011In the assessment of viability, one should separate postinfarction patients from those who have left ventricular systolic dysfunction on the basis of chronic coronary artery disease. In the former, the two questions to be asked are: Is there any viable myocardium? Is that myocardium susceptible to ischemia? Since tissue has to be viable to become ischemic, any imaging method that can detect ischemia will answer the second question. A patient with a moderate to large amount of ischemic myocardium is a candidate for a revascularization procedure. The benefit of uncovering viability in postinfarction patients who do not have ischemia is unknown. If most of the myocardium in an infarct zone is viable and not susceptible to ischemia, then recovery of resting function in that zone will occur spontaneously within weeks.5121314 If the endocardium is necrosed, however, spontaneous recovery in resting function will not occur. Although it is not proven, knowledge of whether there is substantial nonischemic viable myocardium in the middle and outer layers of the left ventricular wall may provide prognostic information and may also be valuable in selecting patients most likely to benefit from angiotensin-converting enzyme inhibitors. In patients with chronic coronary artery disease and reduced global left ventricular systolic function, the most difficult question usually is whether the global dysfunction is due to ischemia or other causes. Many such patients have comorbidity, such as hypertension, that can also result in a reduction in global function. Even in patients with reduced function associated with chronic coronary artery disease, it may be important to assess viability in the different myocardial layers. For instance, many patients with remote infarction and partial-thickness scarring will not show recovery in regional function after revascularization, whereas those with viable myocardium throughout the entire wall may show immediate recovery in function. Another important clinical issue relates to assessing the benefits of revascularization in patients with chronic ischemic heart disease and global left ventricular systolic dysfunction. Assessment of resting global systolic function alone may underestimate the level of benefit received. Even in the absence of improved resting global function, patients may feel better and have a reduction in their cardiac size and filling pressures, and their exercise capacity may improve. They may also no longer be susceptible to exercise-induced ischemia and pulmonary edema. Consequently, the assessment of cardiac volumes, anaerobic threshold, and left ventricular systolic function during exercise may provide a better assessment of the benefit from revascularization than the measurement of resting systolic function alone. In the postinfarction reperfused myocardium, the degree of contractile reserve provides an excellent assessment of the quantum of viable myocardium if there is no residual stenosis limiting hyperemic flow.8 A number of catecholamines have been used to evaluate contractile reserve. If blood flow does not increase commensurate with the increase in myocardial oxygen consumption caused by these agents, ischemia will result and wall thickening will decrease. Consequently, the degree of residual infarct-related artery stenosis will determine the contractile response for a given amount of viable myocardium. A mild stenosis (<50% luminal diameter narrowing) will not attenuate the contractile reserve, whereas a critical stenosis (>85%) will completely attenuate it. In many instances, the residual stenosis after reperfusion is not critical (≤85%), and thus variable degrees of attenuation of the contractile responses will be seen at various doses of dobutamine. As a result, the contractile response may be maximal at doses of 5 to 10 μg · kg−1 · min−1 of dobutamine and may diminish at higher doses (the so-called “biphasic response”).15Thus, although the presence of viability may be detected when there is a residual stenosis, the amount of viability in the infarct zone cannot be quantified on the basis of the magnitude of thickening elicited during dobutamine.16 It is obvious, however, that if the myocardium responds to a low dose of dobutamine, the infarct is probably small and located in the endocardium. Not surprisingly, therefore, the response of the myocardium to a low dose of dobutamine is highly predictive of spontaneous recovery in regional function,15 since patients with small endocardial infarcts are the subset that shows recovery in resting regional function after reperfusion.5121314One of the intriguing findings reported by deFilippi et al17 in this issue of Circulation and by these18 and other authors in other recent publications1920 is the presence of contractile reserve in patients with chronic coronary artery disease and reduced regional function. It has heretofore been believed that regional dysfunction seen in hibernation is due to reduction in resting blood flow to the myocardium. Thus, flow and function are coupled in a parallel manner to that noted in acute ischemia, in which reduction in flow results in a commensurate reduction in function (Fig 3).212223 If the situation were identical to acute ischemia, catecholamine stimulation would result in increased myocardial oxygen consumption, which in the absence of a concomitant increase in blood flow would cause worsening dysfunction. Downregulation of metabolism in the presence of slowly developing ischemia,24 however, may result in a rightward shift of the flow-function relation such that the reduction in function may be more than the reduction in flow (Fig 3). In this situation, low-dose dobutamine may result in an improvement in function, with further increase in the dose of dobutamine causing ischemia-mediated worsening of function (the biphasic response). The hibernating myocardium may not be entirely described by this one relation, however. For example, patients who either have a small infarction or do not infarct during coronary occlusion because of good collateral flow may have normal or near-normal resting flow2526 but may experience repeated episodes of ischemia during routine daily activities, and the myocardium may demonstrate dysfunction simply because it never recovers from repetitive stunning. A similar situation may exist when the coronary artery supplying the myocardium has a severe but subcritical stenosis. In this setting, although resting myocardial flow may be normal, repeated episodes of ischemia may result from even modest levels of exertion, causing the myocardium to appear perpetually “stunned.” In these settings, the degree of vascular reserve and the amount of viable myocardium will influence the response to catecholamines. If there is a significant amount of viability and some vascular reserve, improvement in function will be observed at low doses of dobutamine. By contrast, if the endocardium is necrosed and vascular reserve is good, then increased thickening will be noted only at moderate to high doses of dobutamine. The heterogeneity in the myocardial response to dobutamine seen by deFilippi and others17181920 may therefore potentially provide insights into the underlying pathophysiology of myocardial dysfunction in individual patients and in specific myocardial segments. The assessment of microvascular integrity within the myocardium is also gaining credence as a method of assessing myocardial viability. Normal microvasculature and normal microvascular reserve are present in regions of viable myocardium, whereas regions of necrosis have either abnormal microvasculature or abnormal microvascular reserve.272829 Myocardial contrast echocardiography has the spatial resolution to examine the different myocardial layers of the left ventricular wall for microvascular function. The assessment of viability by use of this technique has been demonstrated previously in postinfarction patients by several investigators.30313233 The report of deFilippi and colleagues17 in this issue of Circulation is the first description of this technique in patients with chronic coronary artery disease. It is too early to tell which of these two aspects of viability (contractile or microvascular reserve) is more accurate in this subset of patients. Since our understanding of viability is rudimentary at present, more than one method, as implied by deFilippi and colleagues,17 may be necessary at times to make the correct management decisions in complex cases. There may be much more to myocardial viability than meets the eye. Although recovery in function spontaneously or after successful revascularization is the best possible outcome, there may be other advantages of viable myocardium. We are at the dawn of an exciting era in our further understanding of coronary pathophysiology in humans, and it will be years before we fully understand the multiple mechanisms responsible for regional and global dysfunction in patients with coronary artery disease and the prognostic and therapeutic implications of these mechanisms. Although clinical studies are vital for this understanding, we should be careful to interpret clinical findings in the context of defined pathophysiological principles. Medicine without physiology is merely phenomenology. We have too much of that already. Download figureDownload PowerPoint Figure 1. M-mode echocardiographic tracing in which sutures have been placed within the myocardium at various depths. Contribution of the different myocardial layers to total wall thickening decreases from the endocardium (Endo) to the epicardium. Reproduced with permission from Reference 3.Download figureDownload PowerPoint Figure 2. Diagram. Nontransmural infarcts, because of a surrounding rim of normal myocardium, will not expand, and the left ventricle will not dilate (top). In contrast, large transmural infarcts without a normal rim of tissue to buttress them will expand and result in left ventricular (LV) dilatation (bottom). Reproduced with permission from Kaul S. Echocardiographic assessment of myocardial viability. In: Iskandrian AS, van der Wall EE, eds. Myocardial Viability. Detection and Clinical Relevance. Dordrecht, Netherlands: Kluwer Academic Publishers; 1994:71.Download figureDownload PowerPoint Figure 3. Graph showing flow-function relation in anesthetized open-chest dogs with selective cannulation of the left circumflex coronary artery and flow altered using a roller-pump. Solid line denotes the relation during acute changes in flow; dotted line represents a hypothetical situation during chronic and gradual decrease in flow. See text for details. Adapted with permission from Reference 21.Supported in part by a grant (R01-HL-48890) from the National Institutes of Health, Bethesda, Md, and an Established Investigator Award from the National Center of the American Heart Association, Dallas, Tex. The author acknowledges the helpful critique of the manuscript by Ian J. Sarembock, MD, and Jonathan R. Lindner, MD. FootnotesCorrespondence to Sanjiv Kaul, MD, Cardiovascular Division, University of Virginia Medical Center, Box 158, Charlottesville, VA 22908. References 1 Oxford English Dictionary. Oxford, UK: Oxford University Press; 1971.Google Scholar2 Gropler RJ, Bergmann SR. Myocardial viability: what is the definition? J Nucl Med.1991; 32:10-12. Editorial. MedlineGoogle Scholar3 Myers JH, Stirling MC, Choy M, Buda AJ, Gallagher KP. Direct measurement of inner and outer wall thickening dynamics with epicardial echocardiography. Circulation.1986; 74:164-172. CrossrefMedlineGoogle Scholar4 Weintraub WS, Hattori S, Aggarwal JB, Bodenheimer MM, Banka V, Helfant RH. The relationship between myocardial blood flow and contraction by myocardial layer in the canine left ventricle during ischemia. Circ Res.1981; 48:430-438. CrossrefMedlineGoogle Scholar5 Touchstone DA, Beller GA, Nygaard TW, Tedesco C, Kaul S. Effects of successful intravenous reperfusion therapy on regional myocardial function and geometry in man: a tomographic assessment using two-dimensional echocardiography. J Am Coll Cardiol.1989; 13:1506-1513. CrossrefMedlineGoogle Scholar6 Lieberman AN, Weiss JL, Jugdutt BI, Becker LC, Bulkley BH, Garrison JG, Hutchins GM, Kallman CA, Weisfeldt ML. Two-dimensional echocardiography and infarct size: relationship of regional wall motion and thinning to the extent of myocardial infarction in the dog. Circulation.1981; 63:739-746. CrossrefMedlineGoogle Scholar7 Villanueva FS, Spotnitz WD, Jayaweera AR, Gimple LW, Dent J, Kaul S. On-line intraoperative quantitation of regional myocardial perfusion during coronary artery bypass graft operations with myocardial contrast two-dimensional echocardiography. J Thorac Cardiovasc Surg.1992; 104:1524-1531. CrossrefMedlineGoogle Scholar8 Sklenar J, Villanueva FS, Glasheen WP, Ismail S, Goodman NC, Kaul S. Dobutamine echocardiography for determining the extent of myocardial salvage after reperfusion: an experimental evaluation. Circulation.1994; 90:1503-1512. Google Scholar9 Eaton LW, Weiss JL, Bulkley BH, Garrison JB, Weisfeldt ML. Regional cardiac dilatation after acute myocardial infarction. N Engl J Med.1979; 300:57-62. CrossrefMedlineGoogle Scholar10 Pirolo JS, Hutchins GM, Moore GW. Infarct expansion: pathologic analysis of 204 patients with a single myocardial infarct. J Am Coll Cardiol.1986; 7:349-354. CrossrefMedlineGoogle Scholar11 Marino P, Zanolla L, Zardini P. Effect of streptokinase on left ventricular modeling and function after myocardial infarction: the GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto Miocardico) Trial. J Am Coll Cardiol.1989; 14:1149-1158. CrossrefMedlineGoogle Scholar12 Penco M, Romano S, Agati L, Dagianti A, Vitarelli A, Fedele F, Dagianti A. Influence of reperfusion induced by thrombolytic treatment on natural history of left ventricular regional motion abnormality in acute myocardial infarction. Am J Cardiol.1993; 71:1015-1020. CrossrefMedlineGoogle Scholar13 Widimsky P, Cervenka V, Visek V, Sladkova T, Dvorak J, Drdlicka S. First month course of left ventricular asynergy after intracoronary thrombolysis in acute myocardial infarction: a longitudinal echocardiographic study. Eur Heart J.1985; 6:759-765. CrossrefMedlineGoogle Scholar14 Charuzi Y, Beeder C, Marshall LA, Sasaki H, Pack NB, Geft I, Ganz W. Improvement in regional and global left ventricular function after intracoronary thrombolysis: assessment with two-dimensional echocardiography. Am J Cardiol.1984; 53:662-665. CrossrefMedlineGoogle Scholar15 Smart SC, Sawada SC, Ryan T, Segar DS, Atherton L, Berkovitz K, Bourdillon PDV, Feigenbaum H. Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation.1993; 88:405-415. CrossrefMedlineGoogle Scholar16 Sklenar J, Camarano G, Ismail S, Goodman N, Kaul S. The effect of coronary stenosis on contractile reserve after acute myocardial infarction: implications in using dobutamine echocardiography for assessing extent of myocardial salvage after reperfusion. Circulation. 1994;90(suppl I):I-117. Abstract. Google Scholar17 deFilippi CR, Willett DL, Irani WN, Eichhorn EJ, Velasco CE, Grayburn PA. Comparison of myocardial contrast echocardiography and low-dose dobutamine stress echocardiography in predicting recovery of left ventricular function after coronary revascularization in chronic ischemic heart disease. Circulation.1995; 92:2863-2868. CrossrefMedlineGoogle Scholar18 Cigarroa CG, deFilippi CR, Brickner ME, Alvarez LG, Wait MA, Grayburn PA. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation.1993; 88:430-436. CrossrefMedlineGoogle Scholar19 Perrone-Filardi P, Pace L, Prastaro M, Piscione F, Betocchi S, Squame F, Vezzuto P, Soricelli A, Indolfi C, Salvatore M, Chiariello M. Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease. Circulation.1995; 92:2556-2565. Google Scholar20 La Canna G, Alfieri O, Giubbibi R, Gargano M, Ferrari R, Visioli O. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol.1994; 23:617-626. CrossrefMedlineGoogle Scholar21 Kaul S. Echocardiography in coronary artery disease. Curr Prob Cardiol.1990; 15:235-298. CrossrefGoogle Scholar22 Gallagher KP, Matsuzaki M, Koziol JA, Kemper WS, Ross J. Regional myocardial perfusion and wall thickening during ischemia in conscious dogs. Am J Physiol.1984; 247:H727-H738. CrossrefMedlineGoogle Scholar23 Vatner SF. Correlation between acute reductions in myocardial blood flow and function in conscious dogs. Circ Res.1980; 47:201-207. CrossrefMedlineGoogle Scholar24 Arai AE, Grauer SE, Anselone CG, Pantley GA, Bristow D. Metabolic adaptation to a gradual reduction in myocardial blood flow. Circulation.1995; 92:244-252. CrossrefMedlineGoogle Scholar25 Sabia PJ, Powers ER, Jayaweera AR, Ragosta M, Kaul S. Functional significance of collateral blood flow in patients with recent acute myocardial infarction: a study using myocardial contrast echocardiography. Circulation.1992; 85:2080-2089. CrossrefMedlineGoogle Scholar26 Vanoverschelde JJ, Wijns W, Depre C, Essamri B, Heyndrickx GR, Borgers M, Bol A, Melin JA. Mechanisms of chronic regional postischemic dysfunction in humans: new insights from the study of noninfarcted collateral-dependent myocardium. Circulation.1993; 87:1513-1523. CrossrefMedlineGoogle Scholar27 Kloner RA, Ganote CE, Jennings RB. The “no-reflow” phenomenon after temporary coronary occlusion in the dog. J Clin Invest.1974; 54:1496-1508. CrossrefMedlineGoogle Scholar28 White FC, Sanders M, Bloor CM. Regional redistribution of myocardial blood flow after coronary occlusion and reperfusion in the conscious dog. Am J Cardiol.1978; 42:234-243. CrossrefMedlineGoogle Scholar29 West PN, Connors JP, Clark RE, Weldon CS, Ramsey DL, Roberts R, Sobel BE, Williamson JR. Compromised microvascular integrity in ischemic myocardium. Lab Invest.1978; 38:677-684. CrossrefMedlineGoogle Scholar30 Ito H, Tomooka T, Sakai N, Yu H, Higashino Y, Fujii K, Masuyama T, Kitabatake A, Minamino T. Lack of myocardial perfusion immediately after successful thrombolysis: a predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation.1992; 85:1699-1705. CrossrefMedlineGoogle Scholar31 Sabia PJ, Powers ER, Ragosta M, Sarembock IJ, Burwell LR, Kaul S. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N Engl J Med.1992; 372:1825-1831. CrossrefGoogle Scholar32 Ragosta M, Camarano GP, Kaul S, Powers E, Gimple LW. Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction: new insights using myocardial contrast echocardiography. Circulation.1994; 89:2562-2569. CrossrefMedlineGoogle Scholar33 Agati L, Voci P, Bilotta F, Luongo R, Autore C, Penco M, Iacobini C, Fedele F, Dagianti A. Influence of residual perfusion within the infarct zone on the natural history of left ventricular dysfunction after acute myocardial infarction: a myocardial contrast echocardiographic study. J Am Coll Cardiol.1994; 24:336-342.CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Huang J, Yan Z, Fan L, Rui Y and Song X (2017) Left ventricular longitudinal function assessment in rabbits after acute occlusion of left anterior descending coronary artery by two-dimensional speckle tracking imaging, BMC Cardiovascular Disorders, 10.1186/s12872-017-0655-6, 17:1, Online publication date: 1-Dec-2017. Leong C, Lim E, Andriyana A, Al Abed A, Lovell N, Hayward C, Hamilton-Craig C and Dokos S (2016) The role of infarct transmural extent in infarct extension: A computational study, International Journal for Numerical Methods in Biomedical Engineering, 10.1002/cnm.2794, 33:2, (e02794), Online publication date: 1-Feb-2017. Piérard L and Picano E (2015) Myocardial Viability Stress Echocardiography, 10.1007/978-3-319-20958-6_20, (327-350), . Goel P, Bhatia T, Kapoor A, Gambhir S, Pradhan P, Barai S, Tewari S, Garg N, Kumar S, Jain S, Madhusudan P and Murthy S (2014) Left Ventricular Remodeling after Late Revascularization Correlates with Baseline Viability, Texas Heart Institute Journal, 10.14503/THIJ-13-3585, 41:4, (381-388), Online publication date: 1-Aug-2014. Capitanio S, Marini C, Bauckneht M and Sambuceti G (2014) Nuclear Cardiology in Heart Failure, Current Cardiovascular Imaging Reports, 10.1007/s12410-013-9256-7, 7:3, Online publication date: 1-Mar-2014. Katikireddy C, Mann N, Brown D, Van Tosh A and Stergiopoulos K (2014) Evaluation of myocardial ischemia and viability by noninvasive cardiac imaging, Expert Review of Cardiovascular Therapy, 10.1586/erc.11.161, 10:1, (55-73), Online publication date: 1-Jan-2012. Janardhanan R and Beller G (2012) Radionuclide Imaging in Stage B Heart Failure, Heart Failure Clinics, 10.1016/j.hfc.2011.11.004, 8:2, (191-206), Online publication date: 1-Apr-2012. Conte L, Fabiani I, Barletta V, Giannini C, Leo L, Delle Donne M, Palagi C, Nardi C, Dini F, Petronio A, Marzilli M and Di Bello V (2012) The role of cardiovascular imaging to understand the different patterns of post-ischemic remodeling, Journal of Cardiovascular Echography, 10.1016/j.jcecho.2012.04.001, 22:3, (107-117), Online publication date: 1-Sep-2012. Berti V, Sciagrà R, Acampa W, Ricci F, Cerisano G, Gallicchio R, Vigorito C, Pupi A and Cuocolo A (2011) Relationship between infarct size and severity measured by gated SPECT and long-term left ventricular remodelling after acute myocardial infarction, European Journal of Nuclear Medicine and Molecular Imaging, 10.1007/s00259-011-1739-7, 38:6, (1124-1131), Online publication date: 1-Jun-2011. Soman P (2010) Radionuclide Imaging in Heart Failure Clinical Nuclear Cardiology, 10.1016/B978-0-323-05796-7.00048-5, (468-482), . Piérard L and Picano E (2009) Myocardial Viability Stress Echocardiography, 10.1007/978-3-540-76466-3_20, (273-294), . Ernande L, Cachin F, Chabrot P, Durel N, Morand D, Boyer L, Maublant J and Lipiecki J (2009) Rest and low-dose dobutamine Tc-99m-mibi gated-SPECT for early prediction of left ventricular remodeling after a first reperfused myocardial infarction, Journal of Nuclear Cardiology, 10.1007/s12350-009-9098-5, 16:4, (597-604), Online publication date: 1-Aug-2009. Rodriguez-Granillo G, Rosales M, Baum S, Rennes P, Rodriguez-Pagani C, Curotto V, Fernandez-Pereira C, Llaurado C, Risau G, Degrossi E, Doval H and Rodriguez A (2009) Early Assessment of Myocardial Viability by the Use of Delayed Enhancement Computed Tomography After Primary Percutaneous Coronary Intervention, JACC: Cardiovascular Imaging, 10.1016/j.jcmg.2009.03.023, 2:9, (1072-1081), Online publication date: 1-Sep-2009. Bombardini T, Galderisi M, Agricola E, Coppola V, Mottola G and Picano E (2008) Negative stress echo: Further prognostic stratification with assessment of pressure–volume relation, International Journal of Cardiology, 10.1016/j.ijcard.2006.12.093, 126:2, (258-267), Online publication date: 1-May-2008. Chan J, Khafagi F, Young A, Cowan B, Thompson C and Marwick T (2008) Impact of coronary revascularization and transmural extent of scar on regional left ventricular remodelling, European Heart Journal, 10.1093/eurheartj/ehn247, 29:13, (1608-1617), Online publication date: 1-Jul-2008. Nakajima K, Tamaki N, Kuwabara Y, Kawano M, Matsunari I, Taki J, Nishimura S, Yamashina A, Ishida Y and Tomoike H (2008) Prediction of functional recovery after revascularization using quantitative gated myocardial perfusion SPECT: a multi-center cohort study in Japan, European Journal of Nuclear Medicine and Molecular Imaging, 10.1007/s00259-008-0838-6, 35:11, (2038-2048), Online publication date: 1-Nov-2008. Cortigiani L, Rigo F, Gherardi S, Sicari R, Galderisi M, Bovenzi F and Picano E (2007) Additional Prognostic Value of Coronary Flow Reserve in Diabetic and Nondiabetic Patients With Negative Dipyridamole Stress Echocardiography by Wall Motion Criteria, Journal of the American College of Cardiology, 10.1016/j.jacc.2007.06.027, 50:14, (1354-1361), Online publication date: 1-Oct-2007. Jin J, Teng G, Feng Y, Wu Y, Jin Q, Wang Y, Wang Z, Lu Q, Jiang Y, Wang S, Chen F, Marchal G and Ni Y (2007) Magnetic Resonance Imaging of Acute Reperfused Myocardial Infarction: Intraindividual Comparison of ECIII-60 and Gd-DTPA in a Swine Model, CardioVascular and Interventional Radiology, 10.1007/s00270-006-0004-0, 30:2, (248-256), Online publication date: 1-Apr-2007. Udelson J, Finley J and Dilsizian V (2007) Comparison of Imaging Modalities in the Assessment of Myocardial Viability Cardiac PET and PET/CT Imaging, 10.1007/978-0-387-38295-1_21, (295-328), . Karagiannis S, Feringa H, Bax J, Elhendy A, Dunkelgrun M, Vidakovic R, Hoeks S, van Domburg R, Valhema R, Cokkinos D and Poldermans D (2007) Myocardial viability estimation during the recovery phase of stress echocardiography after acute beta-blocker administration, European Journal of Heart Failure, 10.1016/j.ejheart.2006.10.018, 9:4, (403-408), Online publication date: 1-Apr-2007. Habis M, Capderou A, Ghostine S, Daoud B, Caussin C, Riou J, Brenot P, Angel C, Lancelin B and Paul J (2007) Acute Myocardial Infarction Early Viability Assessment by 64-Slice Computed Tomography Immediately After Coronary Angiography, Journal of the American College of Cardiology, 10.1016/j.jacc.2006.12.032, 49:11, (1178-1185), Online publication date: 1-Mar-2007. Yamada S and Komuro K (2006) Integrated backscatter for the assessment of myocardial viability, Current Opinion in Cardiology, 10.1097/01.hco.0000240578.05053.f9, 21:5, (433-437), Online publication date: 1-Sep-2006. Atar S, Barbagelata A and Birnbaum Y (2006) Electrocardiographic Diagnosis of ST-elevation Myocardial Infarction, Cardiology Clinics, 10.1016/j.ccl.2006.04.008, 24:3, (343-365), Online publication date: 1-Aug-2006. Schinkel A, Poldermans D, Elhendy A and Bax J (2006) Imaging Techniques for Assessment of Viability and Hibernation Noninvasive Imaging of Myocardial Ischemia, 10.1007/1-84628-156-3_16, (259-275), . Zaglavara T, Karvounis H, Haaverstad R, Pillay T, Hamilton J, Hasan A," @default.
• W2049500768 created "2016-06-24" @default.
• W2049500768 creator A5063537486 @default.
• W2049500768 date "1995-11-15" @default.
• W2049500768 modified "2023-10-18" @default.
• W2049500768 title "There May Be More to Myocardial Viability Than Meets the Eye!" @default.
• W2049500768 cites W1978722924 @default.
• W2049500768 cites W1995359652 @default.
• W2049500768 cites W1998161660 @default.
• W2049500768 cites W2007046182 @default.
• W2049500768 cites W2033166407 @default.
• W2049500768 cites W2037250803 @default.
• W2049500768 cites W2041391028 @default.
• W2049500768 cites W2070876793 @default.
• W2049500768 cites W2137954598 @default.
• W2049500768 cites W2140233303 @default.
• W2049500768 cites W2287166658 @default.
• W2049500768 cites W2312196299 @default.
• W2049500768 cites W2331799472 @default.
• W2049500768 cites W2336654288 @default.
• W2049500768 cites W2410521232 @default.
• W2049500768 cites W4233637655 @default.
• W2049500768 doi "https://doi.org/10.1161/01.cir.92.10.2790" @default.
• W2049500768 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7586241" @default.
• W2049500768 hasPublicationYear "1995" @default.
• W2049500768 type Work @default.
• W2049500768 sameAs 2049500768 @default.
• W2049500768 citedByCount "118" @default.
• W2049500768 countsByYear W20495007682012 @default.
• W2049500768 countsByYear W20495007682014 @default.
• W2049500768 countsByYear W20495007682015 @default.
• W2049500768 countsByYear W20495007682016 @default.
• W2049500768 countsByYear W20495007682017 @default.
• W2049500768 crossrefType "journal-article" @default.
• W2049500768 hasAuthorship W2049500768A5063537486 @default.
• W2049500768 hasConcept C164705383 @default.
• W2049500768 hasConcept C71924100 @default.
• W2049500768 hasConceptScore W2049500768C164705383 @default.
• W2049500768 hasConceptScore W2049500768C71924100 @default.
• W2049500768 hasIssue "10" @default.
• W2049500768 hasLocation W20495007681 @default.
• W2049500768 hasLocation W20495007682 @default.
• W2049500768 hasOpenAccess W2049500768 @default.
• W2049500768 hasPrimaryLocation W20495007681 @default.
• W2049500768 hasRelatedWork W1531601525 @default.
• W2049500768 hasRelatedWork W2748952813 @default.
• W2049500768 hasRelatedWork W2758277628 @default.
• W2049500768 hasRelatedWork W2899084033 @default.
• W2049500768 hasRelatedWork W2935909890 @default.
• W2049500768 hasRelatedWork W2948807893 @default.
• W2049500768 hasRelatedWork W3173606202 @default.
• W2049500768 hasRelatedWork W3183948672 @default.
• W2049500768 hasRelatedWork W2778153218 @default.
• W2049500768 hasRelatedWork W3110381201 @default.
• W2049500768 hasVolume "92" @default.
• W2049500768 isParatext "false" @default.
• W2049500768 isRetracted "false" @default.
• W2049500768 magId "2049500768" @default.
• W2049500768 workType "article" @default.